Global Lung Cancer Therapeutics Market Growth, Trends & Forecasts 2017 - 2022

  • ID: 4387073
  • Report
  • Region: Global
  • 208 pages
  • Mordor Intelligence
1 of 4
The Global market for Lung Cancer Therapeutics is expected to reach $8.5 billion by the end of 2020 growing at a CAGR of around 6% from 2014 to 2021. Lung Cancer is the lethal lung tumor portrayed by the undisciplined growth of cells in the lung tissues. Cigarette smoking is the principal risk factor for the development of lung cancer. Prolonged exposure to tobacco smoke can also cause lung cancer. The interpretation of lung cancer is confirmed by biopsy which is carried out using bronchoscopy or CT-guidance. The two different types of lung cancer are small cell lung cancer & non-small cell lung cancer. Treatment of lung cancer can be done by chemotherapy, radiotherapy, surgery, etc.

The largest number of cancer deaths in both men and women is because of lung cancer. The lung cancer therapeutics market is segmented on the basis of Chemotherapy, Drugs, Radiotherapy (External beam radiotherapy, Internal radiotherapy and Systemic radiotherapy) and Region (North America, Europe, Asia Pacific and Rest of the World).

Drivers

Government funding in the field of research and development of new drugs, increasing pollution due to rapid industrialization and rise in the number of smokers are some of the reasons driving the growth of the market.

Challenges

Large number of players in the market and in turn large number of drugs available in the market are the major constraints faced by the market.

This Report Offers:

Market Definition for the specified topic along with identification of key drivers and restraints for the market.

Market analysis for the Global Lung Cancer Therapeutics Market, with region specific assessments and competition analysis on a global and regional scale.

Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.

Identification and analysis of the Macro and Micro factors that affect the Global Lung Cancer Therapeutics Market on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
1. Introduction
1.1 Report Description
1.2 Markets Covered
1.3 Research Methodology
2. Executive Summary
3. Market Overview
3.1 Market Definition
3.2 Market Drivers
3.2.1 Government funding in the field of research and development of new drugs
3.2.2 Increasing pollution due to rapid industrialization
3.2.3 Rise in the number of smokers
3.3 Market Restraints
3.3.1 Large number of players in the market and in turn large number of drugs available in the market
3.4 Market Opportunitites
3.5 Market Threats
4. Porters Five Force Analysis
4.1 Bargaining Power of suppliers
4.2 Bargaining power of buyers
4.3 Degree of competition
4.4 Threat of substitution
4.5 Threat of new entrants
5. Market Segmentation
5.1 Global Lung Cancer Therapeutics Market
5.1.1 By Chemotherapy
5.1.1.1 Cisplatin
5.1.1.2 Taxol
5.1.1.3 Navelbine
5.1.1.4 Camptosar
5.1.1.5 Alimta
5.1.2 By Radiotherapy
5.1.2.1 External Beam
5.1.2.2 Internal
5.1.2.3 Systemic
5.1.3 By Drugs
5.1.3.1 Abraxane
5.1.3.2 Avastin
5.1.3.3 Crizotinib
5.1.3.4 Docetaxel
5.1.3.5 Gefitinib
5.1.4 By Geography
5.1.4.1 North America
5.1.4.1.1 USA
5.1.4.1.2 Canada
5.1.4.1.3 Mexico
5.1.4.2 Europe
5.1.4.2.1 UK
5.1.4.2.2 Germany
5.1.4.2.3 France
5.1.4.2.4 Italy
5.1.4.2.5 Spain
5.1.4.3 Asia Pacific
5.1.4.3.1 China
5.1.4.3.2 Japan
5.1.4.3.3 India
5.1.4.3.4 Australia
5.1.4.4 ROW
6. Competitive Landscape
6.1 Mergers & Acquisitions
6.2 Agreements, Collaborations & Partnerships
6.3 New Product Launches
6.4 Recommendations to new market players
7. Company Profiles
7.1 Pfizer
7.2 Ventana
7.3 Roche
7.4 Genentech
7.5 Glaxosmith
7.6 Agennix
7.7 Boehringer

List of Tables

1: Global Lung Cancer Therapeutics Market($ million)(2017 - 2022).
2: Global Lung Cancer Therapeutics Market-By Chemotherapy-($ million)(2017 - 2022).
3: Global Lung Cancer Therapeutics Market-By Chemotherapy-Cisplatin-($ million)(2017 - 2022).
4: Global Lung Cancer Therapeutics Market-By Chemotherapy-Taxol-($ million)(2017 - 2022).
5: Global Lung Cancer Therapeutics Market-By Chemotherapy-Navelbine-($ million)(2017 - 2022).
6: Global Lung Cancer Therapeutics Market-By Chemotherapy-Camptosar-($ million)(2017 - 2022).
7: Global Lung Cancer Therapeutics Market-By Chemotherapy-Alimta-($ million)(2017 - 2022).
8: Global Lung Cancer Therapeutics Market-By Radiation Therapy-($ million)(2017 - 2022).
9: Global Lung Cancer Therapeutics Market-By Radiation Therapy-External Beam-($ million)(2017 - 2022).
10: Global Lung Cancer Therapeutics Market-By Radiation Therapy-Internal-($ million)(2017 - 2022).
11: Global Lung Cancer Therapeutics Market-By Radiation Therapy-Systemic-($ million)(2017 - 2022).
12: Global Lung Cancer Therapeutics Market-By Drugs-($ million)(2017 - 2022).
13: Global Lung Cancer Therapeutics Market-By Drugs-Abraxane-($ million)(2017 - 2022).
14: Global Lung Cancer Therapeutics Market-By Drugs-Avastin-($ million)(2017 - 2022).
15: Global Lung Cancer Therapeutics Market-By Drugs-Crizotinib-($ million)(2017 - 2022).
16: Global Lung Cancer Therapeutics Market-By Drugs-Docetaxel-($ million)(2017 - 2022).
17: Global Lung Cancer Therapeutics Market-By Drugs-Gefitinib-($ million)(2017 - 2022).
18: North American Lung Cancer Therapeutics Market($ million)(2017 - 2022).
19: North American Lung Cancer Therapeutics Market-By Chemotherapy-($ million)(2017 - 2022).
20: North American Lung Cancer Therapeutics Market-By Chemotherapy-Cisplatin-($ million)(2017 - 2022).
21: North American Lung Cancer Therapeutics Market-By Chemotherapy-Taxol-($ million)(2017 - 2022).
22: North American Lung Cancer Therapeutics Market-By Chemotherapy-Navelbine-($ million)(2017 - 2022).
23: North American Lung Cancer Therapeutics Market-By Chemotherapy-Camptosar-($ million)(2017 - 2022).
24: North American Lung Cancer Therapeutics Market-By Chemotherapy-Alimta-($ million)(2017 - 2022).
25: North American Lung Cancer Therapeutics Market-By Radiation Therapy-($ million)(2017 - 2022).
26: North American Lung Cancer Therapeutics Market-By Radiation Therapy-External Beam-($ million)(2017 - 2022).
27: North American Lung Cancer Therapeutics Market-By Radiation Therapy-Internal-($ million)(2017 - 2022).
28: North American Lung Cancer Therapeutics Market-By Radiation Therapy-Systemic-($ million)(2017 - 2022).
29: North American Lung Cancer Therapeutics Market-By Drugs-($ million)(2017 - 2022).
30: North American Lung Cancer Therapeutics Market-By Drugs-Abraxane-($ million)(2017 - 2022).
31: North American Lung Cancer Therapeutics Market-By Drugs-Avastin-($ million)(2017 - 2022).
32: North American Lung Cancer Therapeutics Market-By Drugs-Crizotinib-($ million)(2017 - 2022).
33: North American Lung Cancer Therapeutics Market-By Drugs-Docetaxel-($ million)(2017 - 2022).
34: North American Lung Cancer Therapeutics Market-By Drugs-Gefitinib-($ million)(2017 - 2022).
35: European Lung Cancer Therapeutics Market($ million)(2017 - 2022).
36: European Lung Cancer Therapeutics Market-By Chemotherapy-($ million)(2017 - 2022).
37: European Lung Cancer Therapeutics Market-By Chemotherapy-Cisplatin-($ million)(2017 - 2022).
38: European Lung Cancer Therapeutics Market-By Chemotherapy-Taxol-($ million)(2017 - 2022).
39: European Lung Cancer Therapeutics Market-By Chemotherapy-Navelbine-($ million)(2017 - 2022).
40: European Lung Cancer Therapeutics Market-By Chemotherapy-Camptosar-($ million)(2017 - 2022).
41: European Lung Cancer Therapeutics Market-By Chemotherapy-Alimta-($ million)(2017 - 2022).
42: European Lung Cancer Therapeutics Market-By Radiation Therapy-($ million)(2017 - 2022).
43: European Lung Cancer Therapeutics Market-By Radiation Therapy-External Beam-($ million)(2017 - 2022).
44: European Lung Cancer Therapeutics Market-By Radiation Therapy-Internal-($ million)(2017 - 2022).
45: European Lung Cancer Therapeutics Market-By Radiation Therapy-Systemic-($ million)(2017 - 2022).
46: European Lung Cancer Therapeutics Market-By Drugs-($ million)(2017 - 2022).
47: European Lung Cancer Therapeutics Market-By Drugs-Abraxane-($ million)(2017 - 2022).
48: European Lung Cancer Therapeutics Market-By Drugs-Avastin-($ million)(2017 - 2022).
49: European Lung Cancer Therapeutics Market-By Drugs-Crizotinib-($ million)(2017 - 2022).
50: European Lung Cancer Therapeutics Market-By Drugs-Docetaxel-($ million)(2017 - 2022).
51: European Lung Cancer Therapeutics Market-By Drugs-Gefitinib-($ million)(2017 - 2022).
52: Asia Pacific Lung Cancer Therapeutics Market($ million)(2017 - 2022).
53: Asia Pacific Lung Cancer Therapeutics Market-By Chemotherapy-($ million)(2017 - 2022).
54: Asia Pacific Lung Cancer Therapeutics Market-By Chemotherapy-Cisplatin-($ million)(2017 - 2022).
55: Asia Pacific Lung Cancer Therapeutics Market-By Chemotherapy-Taxol-($ million)(2017 - 2022).
56: Asia Pacific Lung Cancer Therapeutics Market-By Chemotherapy-Navelbine-($ million)(2017 - 2022).
57: Asia Pacific Lung Cancer Therapeutics Market-By Chemotherapy-Camptosar-($ million)(2017 - 2022).
58: Asia Pacific Lung Cancer Therapeutics Market-By Chemotherapy-Alimta-($ million)(2017 - 2022).
59: Asia Pacific Lung Cancer Therapeutics Market-By Radiation Therapy-($ million)(2017 - 2022).
60: Asia Pacific Lung Cancer Therapeutics Market-By Radiation Therapy-External Beam-($ million)(2017 - 2022).
61: Asia Pacific Lung Cancer Therapeutics Market-By Radiation Therapy-Internal-($ million)(2017 - 2022).
62: Asia Pacific Lung Cancer Therapeutics Market-By Radiation Therapy-Systemic-($ million)(2017 - 2022).
63: Asia Pacific Lung Cancer Therapeutics Market-By Drugs-($ million)(2017 - 2022).
64: Asia Pacific Lung Cancer Therapeutics Market-By Drugs-Abraxane-($ million)(2017 - 2022).
65: Asia Pacific Lung Cancer Therapeutics Market-By Drugs-Avastin-($ million)(2017 - 2022).
66: Asia Pacific Lung Cancer Therapeutics Market-By Drugs-Crizotinib-($ million)(2017 - 2022).
67: Asia Pacific Lung Cancer Therapeutics Market-By Drugs-Docetaxel-($ million)(2017 - 2022).
68: Asia Pacific Lung Cancer Therapeutics Market-By Drugs-Gefitinib-($ million)(2017 - 2022).
69: Rest of the World Lung Cancer Therapeutics Market($ million)(2017 - 2022).
70: Rest of the World Lung Cancer Therapeutics Market-By Chemotherapy-($ million)(2017 - 2022).
71: Rest of the World Lung Cancer Therapeutics Market-By Chemotherapy-Cisplatin-($ million)(2017 - 2022).
72: Rest of the World Lung Cancer Therapeutics Market-By Chemotherapy-Taxol-($ million)(2017 - 2022).
73: Rest of the World Lung Cancer Therapeutics Market-By Chemotherapy-Navelbine-($ million)(2017 - 2022).
74: Rest of the World Lung Cancer Therapeutics Market-By Chemotherapy-Camptosar-($ million)(2017 - 2022).
75: Rest of the World Lung Cancer Therapeutics Market-By Chemotherapy-Alimta-($ million)(2017 - 2022).
76: Rest of the World Lung Cancer Therapeutics Market-By Radiation Therapy-($ million)(2017 - 2022).
77: Rest of the World Lung Cancer Therapeutics Market-By Radiation Therapy-External Beam-($ million)(2017 - 2022).
78: Rest of the World Lung Cancer Therapeutics Market-By Radiation Therapy-Internal-($ million)(2017 - 2022).
79: Rest of the World Lung Cancer Therapeutics Market-By Radiation Therapy-Systemic-($ million)(2017 - 2022).
80: Rest of the World Lung Cancer Therapeutics Market-By Drugs-($ million)(2017 - 2022).
81: Rest of the World Lung Cancer Therapeutics Market-By Drugs-Abraxane-($ million)(2017 - 2022).
82: Rest of the World Lung Cancer Therapeutics Market-By Drugs-Avastin-($ million)(2017 - 2022).
83: Rest of the World Lung Cancer Therapeutics Market-By Drugs-Crizotinib-($ million)(2017 - 2022).
84: Rest of the World Lung Cancer Therapeutics Market-By Drugs-Docetaxel-($ million)(2017 - 2022).
85: Rest of the World Lung Cancer Therapeutics Market-By Drugs-Gefitinib-($ million)(2017 - 2022).
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll